Tarun Dasari, MD, Assistant Professor, Department of Medicine/Cardiovascular Diseases
Upon completion of this activity, participants will be able to: Review the mechanisms underlying cardio toxicity of chemotherapeutic agents. To review early detection strategies for asymptomatic left ventricular dysfunction during chemotherapy. To report on the available drug therapy for left ventricular dysfunction post chemotherapy.
Disclosure Report: Course Director: Dr. C. A. Sivaram is a consultant and receives honoraria for Medtronic, Inc. Planning Committee Member: Dr. Dwight Reynolds has received grants/research support from Medtronic and Biotronik. He has been a consultant for and has received honoraria from Medtronic. Dr. Faisal Latif has no financial relationships or affiliations to disclose. Course Contact: Kelsey Peters has no financial relationships or affiliations to disclose. Speaker Disclosure: Dr. Dasari has no financial relationships or affiliations to disclose.
Disclaimer Statement: Statements, opinions and results of studies contained in the program are those of the presenters/authors and do not reflect the policy or position of the Board of Regents of the University of Oklahoma (“OU”) nor does OU provide any warranty as to their accuracy or reliability. Eery reasonable effort has been made to faithfully reproduce the presentations and material as submitted. However, no responsibility is assumed by OU for any claims, injury and/or damage to persons or property from any cause, including negligence or otherwise, or from any use or operation of any methods, products, instruments or ideas contained in the material herein.
For more information contact:
Department of Medicine/Cardiovascular Diseases